Clincosm LogoSign in Get a demo

hematologic malignancy

Showing 26 - 50 of 166
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Cancer, Hematologic Malignancy Trial in Boston (CBT for Fatigue, Usual Care)

Not yet recruiting
  • Hematologic Cancer
  • Hematologic Malignancy
  • CBT for Fatigue
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Feb 3, 2023

Prospective Procurement of Tumor Tissue to Identify Novel

Enrolling by invitation
  • Solid Tumors
  • +7 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Bone Marrow Transplant Complications, Hematologic Malignancy Trial in Boston (CARE Application, Usual Care)

    Not yet recruiting
    • Bone Marrow Transplant Complications
    • Hematologic Malignancy
    • CARE Application
    • Usual Care
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Feb 1, 2023

    Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)

    Active, not recruiting
    • Hematologic Malignancy
    • Milwaukee, Wisconsin
      Froedtert Hospital
    Jan 31, 2023

    Cognitive Impairment, Hematologic Malignancy Trial in Birmingham (Modified ketogenic diet using an exogenous ketogenic formula,

    Recruiting
    • Cognitive Impairment
    • Hematologic Malignancy
    • Modified ketogenic diet using an exogenous ketogenic formula
    • Online cognitive training
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jan 31, 2023

    Cancer, Solid Tumor, Hematologic Malignancy Trial in Hangzhou (engineered red blood cell WTX212)

    Recruiting
    • Cancer
    • +2 more
    • engineered red blood cell WTX212
    • Hangzhou, Zhejiang, China
      Zhejiang Provincial People'S Hospital
    Jan 21, 2023

    Platelet Refractoriness, Hematologic Malignancy Trial in Charlottesville (isatuximab 10 mg/kg)

    Recruiting
    • Platelet Refractoriness
    • Hematologic Malignancy
    • isatuximab 10 mg/kg
    • Charlottesville, Virginia
      University of Virginia
    Jan 27, 2023

    Hematologic Malignancy, Blood Cancer, Lymphoma Trial in Boston (Palliative Care, Usual Care)

    Recruiting
    • Hematologic Malignancy
    • +4 more
    • Palliative Care
    • Usual Care
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Jan 24, 2023

    Hematologic Malignancy, CAR-T Cell Therapy Trial in Boston (Educational Video Tool)

    Active, not recruiting
    • Hematologic Malignancy
    • CAR-T Cell Therapy
    • Educational Video Tool
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jan 24, 2023

    Hematologic Malignancy Trial in Guangzhou (BC3402 Injection)

    Not yet recruiting
    • Hematologic Malignancy
    • BC3402 Injection
    • Guangzhou, Guangdong, China
      The First Affiliated Hospital of Jinan University
    Jan 10, 2023

    Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

    Recruiting
    • Colorectal Cancer
    • +11 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jan 18, 2023

    Solid Tumor, Solid Carcinoma, Solid Tumor, Adult Trial in United States (Benralizumab)

    Recruiting
    • Solid Tumor
    • +3 more
    • Basking Ridge, New Jersey
    • +4 more
    Jan 18, 2023

    Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)

    Recruiting
    • Solid Tumor Malignancy
    • +4 more
    • mRNA-1273
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 14, 2023

    SARS-CoV-2 Infection in Hematologic Tumors

    Active, not recruiting
    • SARS-CoV-2 Infection
    • Hematologic Malignancy
    • None intervention
    • Beijing, Beijing, China
      Peking University First Hospital
    Jan 13, 2023

    Technology to Assess Vulnerable Older Cancer and Their

    Active, not recruiting
    • Cancer
    • +2 more
      • Duarte, California
        City of Hope Medical Center
      Jan 4, 2023

      Hematologic Malignancy Trial in Durham (Interval training, Psychiatric consult, Nutrition/diet evaluation)

      Active, not recruiting
      • Hematologic Malignancy
      • Interval training
      • +3 more
      • Durham, North Carolina
        Duke University Adult Bone Marrow Transplant Clinic
      Dec 16, 2022

      Hematologic Malignancy Trial in Durham (Exercise training)

      Recruiting
      • Hematologic Malignancy
      • Exercise training
      • Durham, North Carolina
        Duke Adult Blood and Marrow Transplant Clinic
      Dec 16, 2022

      Venous Thromboembolism in Hematologic Malignancy and

      Active, not recruiting
      • Thrombosis, Venous
      • +4 more
        • Toronto, Ontario, Canada
          Federico Carini
        Nov 21, 2022

        CB-Long-Term Safety Study (CB-LTSS)

        Enrolling by invitation
        • Lymphoma, Non-Hodgkin
        • +7 more
        • Allogeneic CAR-T therapy
        • Irvine, California
        • +3 more
        Nov 18, 2022

        Hematologic Malignancy, Hematopoietic/Lymphoid Cancer, Blood Cancer Trial in Boston (Positive Psychology Intervention)

        Completed
        Has Results
        • Hematologic Malignancy
        • +2 more
        • Positive Psychology Intervention
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Nov 14, 2022

        Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

        Recruiting
        • Hematologic Malignancy
        • Myeloid Malignancy
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        Nov 7, 2022

        Hematologic Malignancy Trial in Nanchang, Jinan (TQB3702 tablets)

        Not yet recruiting
        • Hematologic Malignancy
        • TQB3702 tablets
        • Nanchang, Jiangxi, China
        • +1 more
        Nov 2, 2022

        CD19 Expressing Malignancies, Hematologic Malignancy Trial in United States (PBCAR19B)

        Recruiting
        • CD19 Expressing Malignancies
        • Hematologic Malignancy
        • PBCAR19B
        • Gilbert, Arizona
        • +6 more
        Nov 8, 2022

        Hematologic Malignancy, Patient Education Trial in Ankara (mobile application)

        Active, not recruiting
        • Hematologic Malignancy
        • Patient Education
        • mobile application
        • Ankara, Yenimahalle, Turkey
          Dr. Abdurrahman Yurtaslan Ankara Onkoloji Eğitim ve Araştırma Ha
        Nov 1, 2022

        Breast Cancer, Hematologic Malignancy, Immune Checkpoint Inhibitor-Related Myocarditis Trial in Weston (anonymized data

        Recruiting
        • Breast Cancer
        • +4 more
        • anonymized data collection during programmed surveillance clinical follow up
        • Weston, Florida
          Cleveland Clinic Florida
        Oct 27, 2022